EVALUATION OF COVID-19 VACCINES EFFICACY IN IRAQI PEOPLES

EVALUATION OF COVID-19 VACCINES EFFICACY IN IRAQI PEOPLES

OBJECTIVEThe aim: The present study was carried out on patients recovered from COVID-19, including those patients who have taken vaccine and those who have not. PATIENTS AND METHODSMaterials and methods: The patients were recruited via an online panel and surveyed at different regions of Iraq from J...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Wiadomości lekarskie (1960) 2022-01, Vol.75 (4 pt 2), p.929-937
Hauptverfasser: Jawad, Mahmood J, Jawad, Mohammed J, Hasan, Iman Sabeeh, Hassan, Saif M, Fatima, Ghizal, Hadi, Najah R
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 937
container_issue 4 pt 2
container_start_page 929
container_title Wiadomości lekarskie (1960)
container_volume 75
creator Jawad, Mahmood J
Jawad, Mohammed J
Hasan, Iman Sabeeh
Hassan, Saif M
Fatima, Ghizal
Hadi, Najah R
description OBJECTIVEThe aim: The present study was carried out on patients recovered from COVID-19, including those patients who have taken vaccine and those who have not. PATIENTS AND METHODSMaterials and methods: The patients were recruited via an online panel and surveyed at different regions of Iraq from June 1, 2021, to August 30, 2021. RESULTSResults: Our results demonstrated that the highest percentage of people recommended Pfizer vaccine followed by Sinopharm, while AstraZeneca vaccine was least recommended. CONCLUSIONConclusions: The efficacy of different vaccines differed significantly; the highest effectiveness was observed with Pfizer vaccine followed by AstraZeneca and Sinopharm with effectiveness ranging from 94%, 89%, and 74%, respectively. Further, the highest percentage of re-infected patients was observed with Sinopharm vaccine followed by Astra Zeneca and Pfizer vaccine, respectively. Also, the highest percent of re-infection with masking used was seen in the case of Sinopharm vaccine followed by AstraZeneca and Pfizer vaccine. Although, we observed that post-vaccination symptoms were lowest than pre-vaccination symptoms, the percent of asymptomatic cases post-vaccination was highest than pre-vaccination cases for all vaccines.
doi_str_mv 10.36740/WLek202204202
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_2671267134</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2671267134</sourcerecordid><originalsourceid>FETCH-LOGICAL-p103t-42f666ee3331d81cece45037d400bd93e7b2508be67c7c6a3802c61f49e6b9673</originalsourceid><addsrcrecordid>eNotjDFPwzAUhD2ARFW6MntkCTz7Oc_xGBkHLEVNoW0QU5U4jgQEWkj7_wmCk-676TvGrgTcIGkFt89lfJcgJaiJZ2wGoDBJhdIXbDGObzCFUgFkZsy4Oi-3-cZXS14V3Fa1v0uE4XVurV-6NXdF4W1uX7hfcv-UP3q-ctWqdOtLdt43wxgX_ztn28Jt7ENSVveTUSYHAXhMlOyJKEZEFF0mQgxRpYC6UwBtZzDqVqaQtZF00IEazEAGEr0ykVpDGufs-u_38L3_OsXxuPt4HUMchuYz7k_jTpIWv0WFP0TpQrk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2671267134</pqid></control><display><type>article</type><title>EVALUATION OF COVID-19 VACCINES EFFICACY IN IRAQI PEOPLES</title><source>Alma/SFX Local Collection</source><creator>Jawad, Mahmood J ; Jawad, Mohammed J ; Hasan, Iman Sabeeh ; Hassan, Saif M ; Fatima, Ghizal ; Hadi, Najah R</creator><creatorcontrib>Jawad, Mahmood J ; Jawad, Mohammed J ; Hasan, Iman Sabeeh ; Hassan, Saif M ; Fatima, Ghizal ; Hadi, Najah R</creatorcontrib><description>OBJECTIVEThe aim: The present study was carried out on patients recovered from COVID-19, including those patients who have taken vaccine and those who have not. PATIENTS AND METHODSMaterials and methods: The patients were recruited via an online panel and surveyed at different regions of Iraq from June 1, 2021, to August 30, 2021. RESULTSResults: Our results demonstrated that the highest percentage of people recommended Pfizer vaccine followed by Sinopharm, while AstraZeneca vaccine was least recommended. CONCLUSIONConclusions: The efficacy of different vaccines differed significantly; the highest effectiveness was observed with Pfizer vaccine followed by AstraZeneca and Sinopharm with effectiveness ranging from 94%, 89%, and 74%, respectively. Further, the highest percentage of re-infected patients was observed with Sinopharm vaccine followed by Astra Zeneca and Pfizer vaccine, respectively. Also, the highest percent of re-infection with masking used was seen in the case of Sinopharm vaccine followed by AstraZeneca and Pfizer vaccine. Although, we observed that post-vaccination symptoms were lowest than pre-vaccination symptoms, the percent of asymptomatic cases post-vaccination was highest than pre-vaccination cases for all vaccines.</description><identifier>ISSN: 0043-5147</identifier><identifier>DOI: 10.36740/WLek202204202</identifier><language>eng</language><ispartof>Wiadomości lekarskie (1960), 2022-01, Vol.75 (4 pt 2), p.929-937</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Jawad, Mahmood J</creatorcontrib><creatorcontrib>Jawad, Mohammed J</creatorcontrib><creatorcontrib>Hasan, Iman Sabeeh</creatorcontrib><creatorcontrib>Hassan, Saif M</creatorcontrib><creatorcontrib>Fatima, Ghizal</creatorcontrib><creatorcontrib>Hadi, Najah R</creatorcontrib><title>EVALUATION OF COVID-19 VACCINES EFFICACY IN IRAQI PEOPLES</title><title>Wiadomości lekarskie (1960)</title><description>OBJECTIVEThe aim: The present study was carried out on patients recovered from COVID-19, including those patients who have taken vaccine and those who have not. PATIENTS AND METHODSMaterials and methods: The patients were recruited via an online panel and surveyed at different regions of Iraq from June 1, 2021, to August 30, 2021. RESULTSResults: Our results demonstrated that the highest percentage of people recommended Pfizer vaccine followed by Sinopharm, while AstraZeneca vaccine was least recommended. CONCLUSIONConclusions: The efficacy of different vaccines differed significantly; the highest effectiveness was observed with Pfizer vaccine followed by AstraZeneca and Sinopharm with effectiveness ranging from 94%, 89%, and 74%, respectively. Further, the highest percentage of re-infected patients was observed with Sinopharm vaccine followed by Astra Zeneca and Pfizer vaccine, respectively. Also, the highest percent of re-infection with masking used was seen in the case of Sinopharm vaccine followed by AstraZeneca and Pfizer vaccine. Although, we observed that post-vaccination symptoms were lowest than pre-vaccination symptoms, the percent of asymptomatic cases post-vaccination was highest than pre-vaccination cases for all vaccines.</description><issn>0043-5147</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNotjDFPwzAUhD2ARFW6MntkCTz7Oc_xGBkHLEVNoW0QU5U4jgQEWkj7_wmCk-676TvGrgTcIGkFt89lfJcgJaiJZ2wGoDBJhdIXbDGObzCFUgFkZsy4Oi-3-cZXS14V3Fa1v0uE4XVurV-6NXdF4W1uX7hfcv-UP3q-ctWqdOtLdt43wxgX_ztn28Jt7ENSVveTUSYHAXhMlOyJKEZEFF0mQgxRpYC6UwBtZzDqVqaQtZF00IEazEAGEr0ykVpDGufs-u_38L3_OsXxuPt4HUMchuYz7k_jTpIWv0WFP0TpQrk</recordid><startdate>20220101</startdate><enddate>20220101</enddate><creator>Jawad, Mahmood J</creator><creator>Jawad, Mohammed J</creator><creator>Hasan, Iman Sabeeh</creator><creator>Hassan, Saif M</creator><creator>Fatima, Ghizal</creator><creator>Hadi, Najah R</creator><scope>7X8</scope></search><sort><creationdate>20220101</creationdate><title>EVALUATION OF COVID-19 VACCINES EFFICACY IN IRAQI PEOPLES</title><author>Jawad, Mahmood J ; Jawad, Mohammed J ; Hasan, Iman Sabeeh ; Hassan, Saif M ; Fatima, Ghizal ; Hadi, Najah R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p103t-42f666ee3331d81cece45037d400bd93e7b2508be67c7c6a3802c61f49e6b9673</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jawad, Mahmood J</creatorcontrib><creatorcontrib>Jawad, Mohammed J</creatorcontrib><creatorcontrib>Hasan, Iman Sabeeh</creatorcontrib><creatorcontrib>Hassan, Saif M</creatorcontrib><creatorcontrib>Fatima, Ghizal</creatorcontrib><creatorcontrib>Hadi, Najah R</creatorcontrib><collection>MEDLINE - Academic</collection><jtitle>Wiadomości lekarskie (1960)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jawad, Mahmood J</au><au>Jawad, Mohammed J</au><au>Hasan, Iman Sabeeh</au><au>Hassan, Saif M</au><au>Fatima, Ghizal</au><au>Hadi, Najah R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>EVALUATION OF COVID-19 VACCINES EFFICACY IN IRAQI PEOPLES</atitle><jtitle>Wiadomości lekarskie (1960)</jtitle><date>2022-01-01</date><risdate>2022</risdate><volume>75</volume><issue>4 pt 2</issue><spage>929</spage><epage>937</epage><pages>929-937</pages><issn>0043-5147</issn><abstract>OBJECTIVEThe aim: The present study was carried out on patients recovered from COVID-19, including those patients who have taken vaccine and those who have not. PATIENTS AND METHODSMaterials and methods: The patients were recruited via an online panel and surveyed at different regions of Iraq from June 1, 2021, to August 30, 2021. RESULTSResults: Our results demonstrated that the highest percentage of people recommended Pfizer vaccine followed by Sinopharm, while AstraZeneca vaccine was least recommended. CONCLUSIONConclusions: The efficacy of different vaccines differed significantly; the highest effectiveness was observed with Pfizer vaccine followed by AstraZeneca and Sinopharm with effectiveness ranging from 94%, 89%, and 74%, respectively. Further, the highest percentage of re-infected patients was observed with Sinopharm vaccine followed by Astra Zeneca and Pfizer vaccine, respectively. Also, the highest percent of re-infection with masking used was seen in the case of Sinopharm vaccine followed by AstraZeneca and Pfizer vaccine. Although, we observed that post-vaccination symptoms were lowest than pre-vaccination symptoms, the percent of asymptomatic cases post-vaccination was highest than pre-vaccination cases for all vaccines.</abstract><doi>10.36740/WLek202204202</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0043-5147
ispartof Wiadomości lekarskie (1960), 2022-01, Vol.75 (4 pt 2), p.929-937
issn 0043-5147
language eng
recordid cdi_proquest_miscellaneous_2671267134
source Alma/SFX Local Collection
title EVALUATION OF COVID-19 VACCINES EFFICACY IN IRAQI PEOPLES
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T13%3A57%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=EVALUATION%20OF%20COVID-19%20VACCINES%20EFFICACY%20IN%20IRAQI%20PEOPLES&rft.jtitle=Wiadomo%C5%9Bci%20lekarskie%20(1960)&rft.au=Jawad,%20Mahmood%20J&rft.date=2022-01-01&rft.volume=75&rft.issue=4%20pt%202&rft.spage=929&rft.epage=937&rft.pages=929-937&rft.issn=0043-5147&rft_id=info:doi/10.36740/WLek202204202&rft_dat=%3Cproquest%3E2671267134%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2671267134&rft_id=info:pmid/&rfr_iscdi=true